Crealb

Human Serum Albumin (Crealb) is a protein-based solution used for volume expansion and to maintain oncotic pressure. Manufactured by Prothya Biosolutions Netherlands B.V., it is suitable for intravenous use.

Human Serum Albumin, also known as Crealb, is primarily used to increase blood volume in conditions where fluid replacement is necessary. It helps to maintain the oncotic pressure in the bloodstream, which is crucial for retaining fluids within the vascular system. This can be particularly important in situations where there is significant fluid loss or when the body's natural albumin levels are low.

When administered intravenously, Human Serum Albumin works to restore and maintain the volume of blood circulating in the body. This can help to improve overall circulation and ensure that vital organs receive adequate blood flow. The effects are typically seen relatively quickly after administration, as the solution integrates into the bloodstream.

Human Serum Albumin should be handled with care to ensure it remains sterile and free from contamination. It is important to follow proper procedures for intravenous administration to minimize the risk of infection or other complications. Always consult healthcare guidelines for appropriate use and handling.

Human Serum Albumin may interact with certain medications or treatments, particularly those that affect blood volume or circulation. It is advisable to inform healthcare providers about all current medications and treatments before using Human Serum Albumin. Additionally, interactions with other intravenous solutions should be considered to avoid adverse effects.